TOVX
Theriva Biologics·AMEX
--
--(--)
--
--(--)
TOVX fundamentals
During Q4 2025, Theriva Biologics (TOVX) reported revenue of --, a YoY change of 0.00%. Net income was -2.00M, a YoY change of 55.12%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2015 | Q3,2015 | Q4,2015 | Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Apr 1, 2015 | Jul 1, 2015 | Oct 1, 2015 | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Jun 30, 2015 | Sep 30, 2015 | Dec 31, 2015 | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 9.73M -- | 11.65M -- | 11.39M -- | 10.58M -- | 9.31M -4.31% | 9.16M -21.41% | 10.20M -10.44% | 8.15M -22.98% | 6.47M -30.46% | 5.84M -36.19% | 5.78M -43.33% | 4.99M -38.77% | 5.00M -22.73% | 4.32M -26.05% | 3.26M -43.66% | 3.57M -28.42% | 3.64M -27.28% | 5.24M +21.34% | 3.21M -1.47% | 3.03M -15.23% | 2.89M -20.59% | 2.11M -59.73% | 2.13M -33.58% | 2.54M -16.22% | 3.20M +10.66% | 3.27M +55.14% | 5.26M +146.95% | 4.25M +67.60% | 5.03M +57.21% | 4.99M +52.24% | 7.32M +38.97% | 5.18M +21.78% | 5.82M +15.80% | 4.22M -15.40% | 6.22M -15.03% | 5.39M +4.13% | 8.49M +45.84% | 7.89M +86.98% | 4.58M -26.33% | 4.42M -18.08% | 13.13M +54.71% | 4.44M -43.70% | 2.06M -54.96% | 24.05M -- |
Selling, General and Administrative Expenses | 2.22M -- | 1.60M -- | 2.54M -- | 2.43M -- | 2.15M -3.38% | 2.10M +30.61% | 3.48M +37.08% | 2.09M -13.85% | 1.64M -23.43% | 1.71M -18.62% | 2.03M -41.67% | 1.62M -22.49% | 1.43M -12.96% | 1.47M -13.55% | 1.20M -40.70% | 1.15M -28.77% | 1.04M -27.04% | 1.10M -25.51% | 1.28M +6.74% | 1.39M +20.71% | 1.29M +23.18% | 1.20M +9.02% | 1.15M -10.13% | 1.42M +1.87% | 1.26M -1.63% | 1.30M +8.86% | 2.49M +115.61% | 1.66M +16.63% | 1.54M +21.82% | 2.42M +85.42% | 4.25M +70.80% | 2.20M +32.99% | 2.69M +74.37% | 212.00K -91.23% | 2.02M -52.40% | 1.93M -12.18% | 1.47M -45.40% | 2.30M +985.85% | 1.69M -16.18% | 1.45M -25.04% | 11.18M +662.03% | 1.89M -17.94% | 931.00K -45.04% | 15.45M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 5.03M -- | -- -- | -- -- | -- -- | 6.47M +28.73% | -- -- | -- -- | -- -- | 9.86M +52.27% | -- -- | -- -- | 212.00K -- | 2.02M -79.50% | 1.93M -- | 1.47M -- | 2.30M +985.85% | 1.69M -16.18% | 1.45M -25.04% | 11.18M +662.03% | 1.89M -17.94% | 931.00K -45.04% | 15.45M -- |
Research and Development Expenses | 7.51M -- | 10.05M -- | 8.86M -- | 8.15M -- | 7.16M -4.58% | 7.06M -29.71% | 6.73M -24.03% | 6.06M -25.70% | 4.83M -32.57% | 4.14M -41.41% | 3.76M -44.18% | 3.37M -44.38% | 3.57M -26.06% | 2.85M -31.21% | 2.06M -45.26% | 2.42M -28.25% | 2.59M -27.38% | 4.14M +45.61% | 1.93M -6.27% | 1.64M -32.38% | 1.60M -38.20% | 914.00K -77.94% | 979.00K -49.20% | 1.12M -31.62% | 1.93M +20.52% | 1.97M +115.75% | 2.78M +183.86% | 2.60M +132.29% | 3.48M +80.38% | 2.57M +30.32% | 3.07M +10.51% | 2.98M +14.63% | 3.13M -10.10% | 4.01M +55.88% | 4.20M +36.63% | 3.46M +16.19% | 2.95M -5.75% | 2.73M -31.75% | 2.89M -31.22% | 2.97M -14.19% | 1.95M -33.86% | 2.55M -6.69% | 1.13M -60.78% | 8.60M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | 4.07M -- | 2.85M -- | 0 -- | -- -- | 0 -100.00% | 0 -100.00% | 0 -- | -- -- |
Operating Income | -9.73M -- | -11.65M -- | -11.39M -- | -10.58M -- | -9.31M +4.31% | -9.16M +21.41% | -10.20M +10.44% | -8.15M +22.98% | -6.47M +30.46% | -5.84M +36.19% | -5.78M +43.33% | -4.99M +38.77% | -5.00M +22.73% | -4.32M +26.05% | -3.26M +43.66% | -3.57M +28.42% | -3.64M +27.28% | -5.24M -21.34% | -3.21M +1.47% | -3.03M +15.23% | -2.89M +20.59% | -2.11M +59.73% | -2.13M +33.58% | -2.54M +16.22% | -3.20M -10.66% | -3.27M -55.14% | -5.26M -146.95% | -4.25M -67.60% | -5.03M -57.21% | -4.99M -52.24% | -7.32M -38.97% | -5.18M -21.78% | -5.82M -15.80% | -4.22M +15.40% | -6.22M +15.03% | -5.39M -4.13% | -8.49M -45.84% | -7.89M -86.98% | -4.58M +26.33% | -4.42M +18.08% | -13.13M -54.71% | -4.44M +43.70% | -2.06M +54.96% | -24.05M -- |
Non-Operating Income (Loss) | -3.89M -- | 4.14M -- | 96.00K -- | -497.00K -- | 3.55M +191.11% | 667.00K -83.90% | 7.73M +7954.17% | 5.09M +1124.35% | 2.16M -39.10% | -5.09M -862.82% | 8.60M +11.16% | 2.66M -47.67% | 789.00K -63.47% | 631.00K +112.40% | 66.00K -99.23% | 44.00K -98.35% | 80.00K -89.86% | 92.00K -85.42% | 66.00K -- | 38.00K -13.64% | 6.00K -92.50% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 2.00K -66.67% | 2.00K -- | 2.00K -- | -21.00K -- | 17.00K +750.00% | 161.00K +7950.00% | 314.00K +15600.00% | 370.00K +1861.90% | 377.00K +2117.65% | 388.00K +140.99% | 308.00K -1.91% | 227.00K -38.65% | 172.00K -54.38% | 161.00K -58.51% | 133.00K -56.82% | 93.00K -59.03% | 74.00K -56.98% | 79.00K -50.93% | 67.00K -49.62% | 313.00K -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -41.00K -- | -- -- | -- -- | 6.00K -- | -4.00K +90.24% | -1.00K -- | -1.00K -- | 3.00K -50.00% | -5.00K -25.00% | -3.00K -200.00% | 20.00K +2100.00% | 14.00K +366.67% | -5.00K -- | 26.00K -- |
Other Non-Operating Income (Loss) | -3.90M -- | 4.14M -- | 95.00K -- | -498.00K -- | 3.51M +190.19% | 666.00K -83.92% | 7.73M +8037.89% | 5.09M +1122.09% | 2.16M -38.54% | -5.09M -864.56% | 8.58M +10.99% | 2.65M -47.84% | 783.00K -63.73% | 626.00K +112.29% | 19.00K -99.78% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -23.00K -- | -9.00K -- | -9.00K -- | 40.00K -- | 6.00K +126.09% | -4.00K +55.56% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | -2.00K -- | -2.00K -- | -1.00K -- | -1.00K -- | -34.00K -1600.00% | -1.00K +50.00% | -1.00K -- | -1.00K -- | -1.00K +97.06% | -4.00K -300.00% | -14.00K -1300.00% | -9.00K -800.00% | -6.00K -500.00% | -5.00K -25.00% | -47.00K -235.71% | -44.00K -388.89% | -80.00K -1233.33% | -92.00K -1740.00% | -66.00K -40.43% | -38.00K +13.64% | -6.00K +92.50% | 0 +100.00% | 0 +100.00% | 0 +100.00% | -2.00K +66.67% | -2.00K -- | -2.00K -- | -2.00K -- | -26.00K -1200.00% | -170.00K -8400.00% | -315.00K -15650.00% | -364.00K -18100.00% | -381.00K -1365.38% | -382.00K -124.71% | -312.00K +0.95% | -228.00K +37.36% | -173.00K +54.59% | -158.00K +58.64% | -138.00K +55.77% | -96.00K +57.89% | -54.00K +68.79% | -65.00K +58.86% | -72.00K +47.83% | -287.00K -- |
Interest Income | 2.00K -- | 2.00K -- | 1.00K -- | 1.00K -- | 34.00K +1600.00% | 1.00K -50.00% | 1.00K -- | 1.00K -- | 1.00K -97.06% | 4.00K +300.00% | 14.00K +1300.00% | 9.00K +800.00% | 6.00K +500.00% | 5.00K +25.00% | 47.00K +235.71% | 44.00K +388.89% | 80.00K +1233.33% | 92.00K +1740.00% | 66.00K +40.43% | 38.00K -13.64% | 6.00K -92.50% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 2.00K -66.67% | 2.00K -- | 2.00K -- | 2.00K -- | 26.00K +1200.00% | 170.00K +8400.00% | 315.00K +15650.00% | 364.00K +18100.00% | 381.00K +1365.38% | 382.00K +124.71% | 312.00K -0.95% | 228.00K -37.36% | 173.00K -54.59% | 158.00K -58.64% | 138.00K -55.77% | 96.00K -57.89% | 54.00K -68.79% | 65.00K -58.86% | 72.00K -47.83% | 287.00K -- |
Pretax Income From Continuing Operations | -13.62M -- | -7.51M -- | -11.30M -- | -11.08M -- | -5.76M +57.69% | -8.49M -13.08% | -2.47M +78.12% | -3.06M +72.40% | -4.32M +25.14% | -10.93M -28.75% | 2.81M +213.75% | -2.33M +23.94% | -4.21M +2.34% | -3.69M +66.25% | -3.19M -213.51% | -3.53M -51.68% | -3.56M +15.57% | -5.15M -39.60% | -3.14M +1.50% | -2.99M +15.25% | -2.88M +18.97% | -2.11M +59.01% | -2.13M +32.19% | -2.54M +15.15% | -3.19M -10.82% | -3.27M -55.05% | -5.26M -146.86% | -4.27M -68.43% | -5.01M -56.78% | -4.83M -47.42% | -7.00M -33.06% | -4.81M -12.52% | -5.44M -8.66% | -3.83M +20.62% | -5.91M +15.62% | -5.17M -7.43% | -8.32M -52.78% | -7.73M -101.72% | -4.45M +24.74% | -4.32M +16.28% | -13.06M -57.02% | -4.36M +43.55% | -2.00M +55.12% | -23.74M -- |
Income Tax Expense | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -532.00K -- | -335.00K -- | -558.00K -- | -330.00K -- | -359.00K +32.52% | -527.00K -57.31% | -424.00K +24.01% | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 2.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.43M -- | -- -- | -- -- | -- -- | -1.64M -14.93% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -13.62M -- | -7.51M -- | -11.30M -- | -11.08M -- | -5.76M +57.69% | -8.49M -13.08% | -2.47M +78.12% | -3.06M +72.40% | -4.32M +25.14% | -10.93M -28.75% | 2.81M +213.75% | -2.33M +23.94% | -4.21M +2.34% | -3.69M +66.25% | -3.19M -213.51% | -3.53M -51.68% | -3.56M +15.57% | -5.15M -39.60% | -3.14M +1.50% | -2.99M +15.25% | -2.88M +18.97% | -2.11M +59.01% | -2.13M +32.19% | -2.54M +15.15% | -3.19M -10.82% | -3.27M -55.05% | -5.26M -146.86% | -4.27M -68.43% | -4.48M -40.13% | -4.49M -37.18% | -6.45M -22.46% | -4.48M -4.80% | -5.08M -13.56% | -3.30M +26.44% | -5.49M +14.90% | -5.17M -15.34% | -8.32M -63.57% | -7.73M -133.91% | -4.45M +18.92% | -4.32M +16.28% | -13.06M -57.02% | -4.36M +43.55% | -2.00M +55.12% | -23.74M -- |
Net Income Attributable to Minority Interests | -- -- | -733.00K -- | -315.00K -- | -233.00K -- | -82.00K -- | -136.00K +81.45% | -97.00K +69.21% | -212.00K +9.01% | -60.00K +26.83% | -8.00K +94.12% | -38.00K +60.82% | -10.00K +95.28% | -17.00K +71.67% | -9.00K -12.50% | -19.00K +50.00% | -16.00K -60.00% | -27.00K -58.82% | -30.00K -233.33% | -4.00K +78.95% | -26.00K -62.50% | -16.00K +40.74% | -8.00K +73.33% | -23.00K -475.00% | -1.00K +96.15% | 0 +100.00% | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Owners of the Company | -13.62M -- | -6.77M -- | -10.98M -- | -10.85M -- | -5.68M +58.29% | -8.35M -23.31% | -2.38M +78.37% | -2.85M +73.76% | -4.25M +25.11% | -10.92M -30.76% | 2.85M +220.00% | -2.32M +18.62% | -4.20M +1.36% | -3.68M +66.31% | -3.17M -211.33% | -3.51M -51.64% | -3.53M +15.87% | -5.12M -39.13% | -3.14M +1.04% | -2.96M +15.60% | -2.87M +18.80% | -2.10M +58.93% | -2.11M +32.83% | -2.54M +14.44% | -3.19M -11.44% | -3.27M -55.63% | -5.26M -149.55% | -4.27M -68.49% | -4.48M -40.13% | -4.49M -37.18% | -6.45M -22.46% | -4.48M -4.80% | -5.08M -13.56% | -3.30M +26.44% | -5.49M +14.90% | -5.17M -15.34% | -8.32M -63.57% | -7.73M -133.91% | -4.45M +18.92% | -4.32M +16.28% | -13.06M -57.02% | -4.36M +43.55% | -2.00M +55.12% | -23.74M -- |
Preferred Stock Dividends | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 6.90M -- | 61.00K -- | 59.00K -- | 61.00K -- | 61.00K -99.12% | 11.74M +19150.82% | 459.00K +677.97% | 178.00K +191.80% | 133.00K +118.03% | 3.00K -99.97% | 466.00K +1.53% | 455.00K +155.62% | 583.00K +338.35% | 130.00K +4233.33% | 8.92M +1814.81% | 0 -100.00% | -- -- | -7.40M -5793.85% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 880.00K -- | -- -- | -- -- | -- -- | 7.40M +741.14% | -- -- | -- -- | 340.00K -- | 0 -100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 1.51M -- | -- -- |
Net Income Attributable to Common Stockholders | -13.62M -- | -6.77M -- | -10.98M -- | -10.85M -- | -5.68M +58.29% | -8.35M -23.31% | -2.38M +78.37% | -2.85M +73.76% | -4.25M +25.11% | -17.82M -113.37% | 2.79M +217.43% | -2.38M +16.55% | -4.26M -0.07% | -3.74M +79.01% | -14.92M -634.82% | -3.97M -67.20% | -3.71M +12.89% | -5.25M -40.42% | -3.14M +78.93% | -3.43M +13.62% | -3.32M +10.43% | -2.69M +48.87% | -3.12M +0.76% | -11.46M -234.08% | -3.19M +3.82% | -3.27M -21.85% | -5.26M -68.74% | -4.27M +62.71% | -4.48M -40.13% | -4.83M -47.57% | -6.45M -22.46% | -4.48M -4.80% | -5.08M -13.56% | -3.30M +31.61% | -5.49M +14.90% | -5.17M -15.34% | -8.32M -63.57% | -7.73M -133.91% | -4.45M +18.92% | -4.32M +16.28% | -13.06M -57.02% | -4.36M +43.55% | -3.51M +21.16% | -25.25M -- |
Other Comprehensive Income | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | 181.00K -- | -1.44M -- | -1.53M -- | 2.17M -- | 374.00K +106.63% | -51.00K +96.46% | -702.00K +54.03% | 1.09M -49.65% | -569.00K -252.14% | -172.00K -237.25% | 821.00K +216.95% | -1.29M -218.35% | 654.00K +214.94% | 1.32M +865.70% | -30.00K -103.65% | -8.00K +99.38% | 1.93M -- |
Total Comprehensive Income | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -2.54M -- | -3.19M -- | -3.27M -- | -5.26M -- | -4.09M -61.29% | -5.92M -85.26% | -6.02M -83.84% | -4.28M +18.68% | -4.10M -0.29% | -5.13M +13.25% | -4.00M +33.44% | -4.39M -2.69% | -5.73M -39.72% | -8.49M -65.30% | -6.91M -72.41% | -5.74M -30.53% | -3.67M +36.00% | -11.74M -38.32% | -4.39M +36.41% | -2.00M +65.07% | -21.81M -- |
Total Comprehensive Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.00K -- | 0 -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -2.54M -- | -3.19M -- | -3.27M -- | -5.26M -- | -4.09M -61.36% | -5.92M -85.26% | -6.02M -83.84% | -4.28M +18.68% | -4.10M -0.29% | -5.13M +13.25% | -4.00M +33.44% | -4.39M -2.69% | -5.73M -39.72% | -8.49M -65.30% | -6.91M -72.41% | -5.74M -30.53% | -3.67M +36.00% | -11.74M -38.32% | -4.39M +36.41% | -2.00M +65.07% | -21.81M -- |
Basic EPS | -0.19 -- | -0.08 -- | -0.12 -- | -0.12 -- | -0.06 +68.42% | -0.09 -12.50% | -0.02 +83.33% | -0.02 +83.33% | -0.03 +50.00% | -4.9 -5344.44% | 0.02 +200.00% | -0.65 -3150.00% | -1.16 -3766.67% | -0.93 +81.02% | -0.96 -4900.00% | -0.25 +61.54% | -0.23 +80.17% | -0.31 +66.67% | -0.19 +80.21% | -0.2 +20.00% | -0.18 +21.74% | -0.14 +54.84% | -0.02 +89.47% | -0.13 +35.00% | -0.24 -33.33% | -0.25 -78.57% | -0.04 -100.00% | -0.31 -138.46% | -0.28 -16.67% | -0.3 -20.00% | -0.43 -975.00% | -0.3 +3.23% | -0.34 -21.43% | -4.85 -1516.67% | -0.32 +25.58% | -7.53 -2410.00% | -10.72 -3052.94% | -6.81 -40.41% | -1.6 -400.00% | -1.55 +79.42% | -1.93 +82.00% | -0.45 +93.39% | -0.1 +93.75% | -4.03 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -4.85 -- | -- -- | -7.53 -- | -10.72 -- | -6.81 -40.41% | -- -- | -1.55 +79.42% | -1.93 +82.00% | -0.45 +93.39% | -- -- | -- -- |
Diluted EPS | -0.19 -- | -0.12 -- | -- -- | -0.12 -- | -0.1 +47.37% | -0.09 +25.00% | -- -- | -0.02 +83.33% | -0.03 +70.00% | -4.9 -5344.44% | -- -- | -0.65 -3150.00% | -1.16 -3766.67% | -0.93 +81.02% | -- -- | -0.25 +61.54% | -0.23 +80.17% | -0.31 +66.67% | -- -- | -0.2 +20.00% | -0.18 +21.74% | -0.14 +54.84% | -- -- | -0.13 +35.00% | -0.24 -33.33% | -0.25 -78.57% | -- -- | -0.31 -138.46% | -0.28 -16.67% | -0.3 -20.00% | -- -- | -0.3 +3.23% | -0.34 -21.43% | -4.85 -1516.67% | -- -- | -7.53 -2410.00% | -10.72 -3052.94% | -6.81 -40.41% | -- -- | -1.55 +79.42% | -1.93 +82.00% | -0.45 +93.39% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -4.85 -- | -- -- | -7.53 -- | -10.72 -- | -6.81 -40.41% | -- -- | -1.55 +79.42% | -1.93 +82.00% | -0.45 +93.39% | -- -- | -- -- |
You can ask Aime
What is the revenue and EPS growth rate for Theriva Biologics year over year?What guidance did Theriva Biologics's management provide for the next earnings period?What does Theriva Biologics do and what are its main business segments?What were the key takeaways from Theriva Biologics's earnings call?Did Theriva Biologics beat or miss consensus estimates last quarter?What is Theriva Biologics's gross profit margin?What is the market's earnings forecast for Theriva Biologics next quarter?What factors drove the changes in Theriva Biologics's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
